Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ryokeijutsukanto is a traditional Japanese Kampo medicine (a standardized herbal extract) composed of four botanical ingredients: Poria Sclerotium (Bukuryo), Cinnamomi Cortex (Keihi), Atractylodis Lanceae Rhizoma (Sojutsu), and Glycyrrhizae Radix (Kanzou). It is primarily used to treat symptoms associated with fluid disturbances (suidoku) in traditional medicine, including dizziness, vertigo, palpitations, and headache. In modern clinical practice in Japan, it is an ethical Kampo formulation (prescription drug) often prescribed for Meniere's disease, orthostatic dysregulation, and various forms of dizziness. The drug is thought to work by regulating water metabolism, potentially through the modulation of aquaporin channels, and by stabilizing the autonomic nervous system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ryokeijutsukanto.